"We're very concerned about the innovation and the investment environment in India at the moment," Mike Froman, National Deputy Security Advisor on economic policies to US President Barack Obama, said yesterday.
"I'm very concerned with the deterioration in the environment for protection of US intellectual property rights and innovation in India. The government of India continues to take actions that make it very difficult for US innovative pharmaceutical companies to secure and enforce their patents in India," Froman said.
Froman listed out compulsory licensing, patent issues, preferential market access, localisation as some of the issues of concerns, as a number of influential Senators alleged that the recent Indian policies have been detrimental to the India-US relationship.
"We have a lot of concerns about what's going on today in India especially their emerging market access barriers, protectionist measures," said Senator Rob Portman.
"One is the lack of respect for patents. Basic intellectual property protections are being set aside. They've invalidated and broken American drug patents, as I say. I think these actions are in disregard of WTO rules; I think they're fundamentally disruptive to innovation. I think, frankly, it's a major concern, because it could spread," said the Ohio Senator.
Senator Robert Menendez too piled on to the complaint against India.
"I have been hearing from the pharmaceutical industry, I've been hearing from the high-tech industry, I've been hearing from other industries about how India's inadequate protection, to put it mildly, and enforcement of intellectual property rights is a real challenge," he said.
Noting that India is one of the largest recipients of benefits under the generalised system of preferences (GSP), Senator Orrin Hatch alleged that India is increasingly shutting down US companies out of its markets through a variety of measures, including restricting its imports of products to force companies to manufacture in India.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)